《大行報告》瑞銀上調裕元(00551.HK)目標價至11.3元 評級「中性」
瑞銀發表評級報告指,裕元(00551.HK)首季純利按年跌43%至5,100萬美元,符合早前發出盈警,零售業務收入及盈利均勝於預期,受惠於銷售復甦及營運槓桿,同時毛利率較預期低了1.9個百分點,主要是公司正積極地清庫存。
該行指,管理層有信心今年銷售增長達按年雙位數或以上,該行則預料達中至高雙位數;至於OEM業務,管理層預料,次季訂單仍然承壓,並期望下半年會改善。
該行表示,將公司2023年至25年每股盈測上調2%至4%,並將其目標價由10.9元上調至11.3元,維持其評級為「中性」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.